title: Enhancing therapeutic effects of docetaxel-loaded dendritic copolymer nanoparticles by co-treatment with autophagy inhibitor on breast cancer.
abstract: Dendrimers are synthetic nanocarriers that comprise a highly branched spherical polymer as new, efficient tools for drug delivery. However, the fate of nanocarriers after being internalized into cells has seldom been studied. Docetaxel loaded dendritic copolymer H40-poly(D,L-lactide) nanoparticles, referred to as "DTX-H40-PLA NPs", were prepared and used as a model to evaluate whether the NPs were sequestered by autophagy and fused with lysosomes. Besides being degraded through the endolysosomal pathway, the DTX-loaded H40-PLA NPs were also sequestered by autophagosomes and degraded through the autolysosomal pathway. DTX-loaded H40-PLA NPs may stop exerting beneficial effects after inducing autophagy of human MCF-7 cancer cells. Co-delivery of autophagy inhibitor such as chloroquine and chemotherapeutic drug DTX by dendritic copolymer NPs greatly enhanced cancer cell killing in vitro, and decreased both the volume and weight of the tumors in severe combined immunodeficient mice. These findings provide valuable evidence for development of nanomedicine such as dendritic copolymer NPs for clinical application.
authors.affiliation: 1. School of Life Sciences, Tsinghua University, Beijing 100084, P.R. China; ; 2. The Shenzhen Key Lab of Gene and Antibody Therapy, Division of Life and Health Sciences, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P.R. China;
authors.forename: Xudong
authors.initials: X
authors.lastname: Zhang
authors.affiliation: 1. School of Life Sciences, Tsinghua University, Beijing 100084, P.R. China; ; 2. The Shenzhen Key Lab of Gene and Antibody Therapy, Division of Life and Health Sciences, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P.R. China;
authors.forename: Ying
authors.initials: Y
authors.lastname: Yang
authors.affiliation: 3. Key Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, University of Chinese Academy of Sciences, Guangzhou, Guangdong, 510530, P.R. China;
authors.forename: Xin
authors.initials: X
authors.lastname: Liang
authors.affiliation: 1. School of Life Sciences, Tsinghua University, Beijing 100084, P.R. China; ; 2. The Shenzhen Key Lab of Gene and Antibody Therapy, Division of Life and Health Sciences, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P.R. China;
authors.forename: Xiaowei
authors.initials: X
authors.lastname: Zeng
authors.affiliation: 4. Institute of Allergy and Immunology, School of Medicine, Shenzhen University, Shenzhen 518060, P.R. China.
authors.forename: Zhigang
authors.initials: Z
authors.lastname: Liu
authors.affiliation: 1. School of Life Sciences, Tsinghua University, Beijing 100084, P.R. China; ; 2. The Shenzhen Key Lab of Gene and Antibody Therapy, Division of Life and Health Sciences, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P.R. China;
authors.forename: Wei
authors.initials: W
authors.lastname: Tao
authors.affiliation: 4. Institute of Allergy and Immunology, School of Medicine, Shenzhen University, Shenzhen 518060, P.R. China.
authors.forename: Xiaojun
authors.initials: X
authors.lastname: Xiao
authors.affiliation: 1. School of Life Sciences, Tsinghua University, Beijing 100084, P.R. China; ; 2. The Shenzhen Key Lab of Gene and Antibody Therapy, Division of Life and Health Sciences, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P.R. China;
authors.forename: Hongbo
authors.initials: H
authors.lastname: Chen
authors.affiliation: 1. School of Life Sciences, Tsinghua University, Beijing 100084, P.R. China; ; 2. The Shenzhen Key Lab of Gene and Antibody Therapy, Division of Life and Health Sciences, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P.R. China;
authors.forename: Laiqiang
authors.initials: L
authors.lastname: Huang
authors.affiliation: 1. School of Life Sciences, Tsinghua University, Beijing 100084, P.R. China; ; 2. The Shenzhen Key Lab of Gene and Antibody Therapy, Division of Life and Health Sciences, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P.R. China;
authors.forename: Lin
authors.initials: L
authors.lastname: Mei
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001343:Autophagy / Q000187:drug effects*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002738:Chloroquine / Q000627:therapeutic use*; D050091:Dendrimers / Q000008:administration & dosage*; D004195:Disease Models, Animal; D000077143:Docetaxel; D004337:Drug Carriers / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008247:Lysosomes / Q000737:chemistry; D061986:MCF-7 Cells; D016513:Mice, SCID; D053758:Nanoparticles / Q000008:administration & dosage*; D010588:Phagosomes / Q000737:chemistry; D043823:Taxoids / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D050091:Dendrimers; D004337:Drug Carriers; D043823:Taxoids; D000077143:Docetaxel; D002738:Chloroquine
keywords: Autophagy; Chloroquine; Dendrimers.; Docetaxel; Endocytosis; Nanomedicine